Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
4500 participants
INTERVENTIONAL
2025-06-23
2027-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo Assignment
VK2735 Placebo Comparator Once Weekly
VK2735
VK2735 is a peptide GLP-1 and GIP dual agonist administered Once Weekly
Active Assignment (Dose 1)
VK2735 7.5mg Once Weekly
VK2735
VK2735 is a peptide GLP-1 and GIP dual agonist administered Once Weekly
Active Assignment (Dose 2)
VK2735 12.5mg Once Weekly
VK2735
VK2735 is a peptide GLP-1 and GIP dual agonist administered Once Weekly
Active Assignment (Dose 3)
VK2735 17.5mg Once Weekly
VK2735
VK2735 is a peptide GLP-1 and GIP dual agonist administered Once Weekly
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VK2735
VK2735 is a peptide GLP-1 and GIP dual agonist administered Once Weekly
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Body mass index (BMI) ≥30 kg/m2 OR ≥27 kg/m2 with at least one weight-related co- morbid condition (treated or untreated)
* Weight-related co-morbid conditions include hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease
* Cardiovascular disease includes, for example, ischemic cardiovascular disease, New York Heart Association (NYHA) Functional Class I-III heart failure
* BMI calculated at the Screening visit will be used to determine eligibility
Exclusion Criteria
2. Self-reported body weight change of 5% or more within 3 months of screening
3. Have a prior or planned surgical treatment for obesity (excluding liposuction or abdominoplasty if performed \>1 year prior to screening)
4. Have or plan to have endoscopic and/or device-based therapy for obesity or have had device removal within the last 6 months prior to screening (such as, mucosa ablation, gastric artery embolization, intragastric balloon, duodenal-jejunal endoluminal line)
5. Current or past diagnosis of diabetes mellitus (including type 1, type 2, except gestational diabetes)
6. Treatment with glucose-lowering agent(s) within 90 days before screening
7. Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2)
8. History of acute or chronic pancreatitis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Viking Therapeutics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Viking Clinical Site #1037
Birmingham, Alabama, United States
Viking Clinical Site #1064
Birmingham, Alabama, United States
Viking Clinical Site #1128
Huntsville, Alabama, United States
Viking Clinical Site #1081
Mobile, Alabama, United States
Viking Clinical Site #1005
Chandler, Arizona, United States
Viking Clinical Site #1017
Flagstaff, Arizona, United States
Viking Clinical Site #1018
Peoria, Arizona, United States
Viking Clinical Site #1135
Scottsdale, Arizona, United States
Viking Clinical Site #1019
Tucson, Arizona, United States
Viking Clinical Site #1036
Little Rock, Arkansas, United States
Viking Clinical Site #1071
Chula Vista, California, United States
Viking Clinical Site #1070
Escondido, California, United States
Viking Clinical Site #1054
Huntington Park, California, United States
Viking Clinical Site #1014
Lake Forest, California, United States
Viking Clinical Site #1129
Lemon Grove, California, United States
Viking Clinical Site #1051
Lincoln, California, United States
Viking Clinical Site #1050
Long Beach, California, United States
Viking Clinical Site #1055
Los Angeles, California, United States
Viking Clinical Site #1078
Manteca, California, United States
Viking Clinical Site #1053
Montclair, California, United States
Viking Clinical Site #1068
Panorama City, California, United States
Viking Clinical Site #1132
Rolling Hills Estates, California, United States
Viking Clinical Site #1131
San Diego, California, United States
Viking Clinical Site #1104
Santa Maria, California, United States
Viking Clinical Site #1052
Spring Valley, California, United States
Viking Clinical Site #1109
Tustin, California, United States
Viking Clinical Site #1067
Van Nuys, California, United States
Viking Clinical Site #1079
Walnut Creek, California, United States
Viking Clinical Site #1119
Denver, Colorado, United States
Viking Clinical Site #1123
Washington D.C., District of Columbia, United States
Viking Clinical Site #1013
Clearwater, Florida, United States
Viking Clinical Site #1121
Clearwater, Florida, United States
Viking Clinical Site #1003
Cooper City, Florida, United States
Viking Clinical Site #1112
DeLand, Florida, United States
Viking Clinical Site #1107
Delray Beach, Florida, United States
Viking Clinical Site #1083
Fort Myers, Florida, United States
Viking Clinical Site #1058
Jacksonville, Florida, United States
Viking Clinical Site #1076
Lakeland, Florida, United States
Viking Clinical Site #1060
Lakewood Rch, Florida, United States
Viking Clinical Site #1117
Miami, Florida, United States
Viking Clinical Site #1059
New Port Richey, Florida, United States
Viking Clinical Site #1012
Ocoee, Florida, United States
Viking Clinical Site #1056
Palmetto Bay, Florida, United States
Viking Clinical Site #1011
Port Orange, Florida, United States
Viking Clinical Site #1057
West Palm Beach, Florida, United States
Viking Clinical Site #1116
Atlanta, Georgia, United States
Viking Clinical Site #1030
Columbus, Georgia, United States
Viking Clinical Site #1120
Rincon, Georgia, United States
Viking Clinical Site #1093
Savannah, Georgia, United States
Viking Clinical Site #1025
Woodstock, Georgia, United States
Viking Clinical Site #1062
Honolulu, Hawaii, United States
Viking Clinical Site #1080
Meridian, Idaho, United States
Viking Clinical Site #1006
Chicago, Illinois, United States
Viking Clinical Site #1090
Chicago, Illinois, United States
Viking Clinical Site #1138
Westmont, Illinois, United States
Viking Clinical Site #1127
Valparaiso, Indiana, United States
Viking Clinical Site #1022
West Des Moines, Iowa, United States
Viking Clinical Site #1099
Wichita, Kansas, United States
Viking Clinical Site #1069
Lexington, Kentucky, United States
Viking Clinical Site #1040
Lexington, Kentucky, United States
Viking Clinical Site #1009
Louisville, Kentucky, United States
Viking Clinical Site #1118
Baton Rouge, Louisiana, United States
Viking Clinical Site #1139
Baton Rouge, Louisiana, United States
Viking Clinical Site #1106
Lafayette, Louisiana, United States
Viking Clinical Site #1020
Metairie, Louisiana, United States
Viking Clinical Site #1087
Monroe, Louisiana, United States
Viking Clinical Site #1094
Chevy Chase, Maryland, United States
Viking Clinical Site #1066
Rockville, Maryland, United States
Viking Clinical Site #1103
Boston, Massachusetts, United States
Viking Clinical Site #1001
Methuen, Massachusetts, United States
Viking Clinical Site #1136
Needham, Massachusetts, United States
Viking Clinical Site #1038
Ypsilanti, Michigan, United States
Viking Clinical Site #1140
Gulfport, Mississippi, United States
Viking Clinical Site #1031
City of Saint Peters, Missouri, United States
Viking Clinical Site #1016
Kansas City, Missouri, United States
Viking Clinical Site #1125
Springfield, Missouri, United States
Viking Clinical Site #1108
St Louis, Missouri, United States
Viking Clinical Site #1010
Butte, Montana, United States
Viking Clinical Site #1075
Omaha, Nebraska, United States
Viking Clinical Site #1035
Las Vegas, Nevada, United States
Viking Clinical Site #1034
Reno, Nevada, United States
Viking Clinical Site #1065
Lebanon, New Hampshire, United States
Viking Clinical Site #1095
Marlton, New Jersey, United States
Viking Clinical Site #1029
Albuquerque, New Mexico, United States
Viking Clinical Site #1088
Albany, New York, United States
Viking Clinical Site #1042
East Syracuse, New York, United States
Viking Clinical Site #1096
Hartsdale, New York, United States
Viking Clinical Site #1133
New York, New York, United States
Viking Clinical Site #1142
New York, New York, United States
Viking Clinical Site #1021
The Bronx, New York, United States
Viking Clinical Site #1032
Westfield, New York, United States
Viking Clinical Site #1141
Charlotte, North Carolina, United States
Viking Clinical Site #1122
Durham, North Carolina, United States
Viking Clinical Site #1144
Fayetteville, North Carolina, United States
Viking Clinical Site #1026
Greensboro, North Carolina, United States
Viking Clinical Site #1110
Morehead City, North Carolina, United States
Viking Clinical Site #1061
Morehead City, North Carolina, United States
Viking Clinical Site #1027
Fargo, North Dakota, United States
Viking Clinical Site #1043
Cincinnati, Ohio, United States
Viking Clinical Site #1074
Cincinnati, Ohio, United States
Viking Clinical Site #1044
Cleveland, Ohio, United States
Viking Clinical Site #1089
Columbus, Ohio, United States
Viking Clinical Site #1113
Norman, Oklahoma, United States
Viking Clinical Site #1137
Tulsa, Oklahoma, United States
Viking Clinical Site #1102
Medford, Oregon, United States
Viking Clinical Site #1097
Portland, Oregon, United States
Viking Clinical Site #1126
Portland, Oregon, United States
Viking Clinical Site #1045
East Greenwich, Rhode Island, United States
Viking Clinical Site #1028
Greenville, South Carolina, United States
Viking Clinical Site #1134
Myrtle Beach, South Carolina, United States
Viking Clinical Site #1023
North Charleston, South Carolina, United States
Viking Clinical Site #1004
Knoxville, Tennessee, United States
Viking Clinical Site #1008
Nashville, Tennessee, United States
Viking Clinical Site #1047
Abilene, Texas, United States
Viking Clinical Site #1063
Austin, Texas, United States
Viking Clinical Site #1007
Austin, Texas, United States
Viking Clinical Site #1091
Bellaire, Texas, United States
Viking Clinical Site #1124
Brownsville, Texas, United States
Viking Clinical Site #1049
Dallas, Texas, United States
Viking Clinical Site #1048
Dallas, Texas, United States
Viking Clinical Site #1111
Frisco, Texas, United States
Viking Clinical Site #1046
Houston, Texas, United States
Viking Clinical Site #1077
Lampasas, Texas, United States
Viking Clinical Site #1143
San Antonio, Texas, United States
Viking Clinical Site #1085
San Antonio, Texas, United States
Viking Clinical Site #1073
San Antonio, Texas, United States
Viking Clinical Site #1101
Waco, Texas, United States
Viking Clinical Site #1002
Ogden, Utah, United States
Viking Clinical Site #1092
Salt Lake City, Utah, United States
Viking Clinical Site #1039
Sandy City, Utah, United States
Viking Clinical Site #1024
St. George, Utah, United States
Viking Clinical Site #1098
Arlington, Virginia, United States
Viking Clinical Site #1082
Suffolk, Virginia, United States
Viking Clinical Site #1072
Renton, Washington, United States
Viking Clinical Site #1041
Spokane, Washington, United States
Viking Clinical Site #1130
Mayagüez, , Puerto Rico
Viking Clinical Site #1086
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VK2735-301
Identifier Type: -
Identifier Source: org_study_id